fda update tirzepatide Compounding Update: Reversal & What Pharmacies Need to Know! May 18, 2026: FDA warns

Starting at a low dose and titrating slowlysupported by PlexusDx clinician guidanceminimizes these effects while allowing your body to adapt

Some patients may experience symptoms that superficially resemble POTSsuch as dizziness, palpitations, or lightheadednesswhich are actually related to volume depletion, medication side effects, or rapid weight loss rather than true autonomic dysfunction

Weight regain is common once the medication is discontinued, indicating people may need to remain on these drugs to maintain weight loss

Reply N Engl J Med

At low doses of APAP there is little effect while the hepatotoxicity increases rapidly at high doses